Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Last resort beta-lactam antibiotics for treatment of New-Delhi Metallo-Beta-Lactamase producing Enterobacterales and other Difficult-to-Treat Resistance in Gram-negative bacteria: A real-life study.
Larcher R, Laffont-Lozes P, Roger C, Doncesco R, Groul-Viaud C, Martin A, Loubet P, Lavigne JP, Pantel A, Sotto A. Larcher R, et al. Among authors: laffont lozes p. Front Cell Infect Microbiol. 2022 Dec 5;12:1048633. doi: 10.3389/fcimb.2022.1048633. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36544909 Free PMC article.
Effect of Tocilizumab on Mortality in Patients with SARS-CoV-2 Pneumonia Caused by Delta or Omicron Variants: A Propensity-Matched Analysis in Nimes University Hospital, France.
Laffont-Lozes P, Laureillard D, Loubet P, Stephan R, Chiaruzzi M, Clemmer E, Martin A, Roger C, Muller L, Claret PG, Goulabchand R, Roux C, Lavigne JP, Sotto A, Larcher R. Laffont-Lozes P, et al. Antibiotics (Basel). 2023 Jan 4;12(1):88. doi: 10.3390/antibiotics12010088. Antibiotics (Basel). 2023. PMID: 36671288 Free PMC article.
Correction: Usefulness of dynamic regression time series models for studying the relationship between antimicrobial consumption and bacterial antimicrobial resistance in hospitals: a systematic review.
Laffont-Lozes P, Larcher R, Salipante F, Leguelinel-Blache G, Dunyach-Remy C, Lavigne JP, Sotto A, Loubet P. Laffont-Lozes P, et al. Antimicrob Resist Infect Control. 2024 Mar 21;13(1):33. doi: 10.1186/s13756-024-01387-4. Antimicrob Resist Infect Control. 2024. PMID: 38515203 Free PMC article. No abstract available.
Usefulness of dynamic regression time series models for studying the relationship between antimicrobial consumption and bacterial antimicrobial resistance in hospitals: a systematic review.
Laffont-Lozes P, Larcher R, Salipante F, Leguelinel-Blache G, Dunyach-Remy C, Lavigne JP, Sotto A, Loubet P. Laffont-Lozes P, et al. Antimicrob Resist Infect Control. 2023 Sep 12;12(1):100. doi: 10.1186/s13756-023-01302-3. Antimicrob Resist Infect Control. 2023. PMID: 37697357 Free PMC article. Review.
Evaluation of vaccination coverage in heart failure patients in a tertiary center.
Maire A, Chapet N, Aguilhon S, Laugier ML, Laffont-Lozes P, Rigoni M, Mathieu B, Audurier Y, Breuker C, de Barry G, Jalabert A, Leclercq F, Pasquié JL, Roubille F, Castet-Nicolas A. Maire A, et al. Among authors: laffont lozes p. Heliyon. 2023 Jul 7;9(7):e18080. doi: 10.1016/j.heliyon.2023.e18080. eCollection 2023 Jul. Heliyon. 2023. PMID: 37519644 Free PMC article.
Effect of antimicrobial consumption on Escherichia coli resistance: assessment and forecasting using Dynamic Regression models in a French university hospital (2014-2019).
Laffont-Lozes P, Salipante F, Leguelinel-Blache G, Dunyach-Remy C, Lavigne JP, Sotto A, Larcher R. Laffont-Lozes P, et al. Int J Antimicrob Agents. 2023 May;61(5):106768. doi: 10.1016/j.ijantimicag.2023.106768. Epub 2023 Mar 4. Int J Antimicrob Agents. 2023. PMID: 36878409 Free article.